-transparent.png){kind=logo}
A new non-steroidal anti-inflammatory drug fenflumizole when administered orally to rabbits at therapeutic doses of 10 and 30 mg/kg affects neither PGI2 generation by arterial slices nor PGE2 generation by gastric mucosa, respectively. Fenflumizole at doses of 10 and 30 mg/kg per os inhibits platelet aggregability and generation of TXA2 by platelets. It is suggested that this selective action of fenflumizole on tissue cyclooxygenase ex vivo may justify with fenflumizole in anti-thrombotic therapy.
Related Publications
M Basista, and
L Grodzińska, and
R J Gryglewski
August 2001,
Antisense & nucleic acid drug development,
M Basista, and
L Grodzińska, and
R J Gryglewski
May 1987,
Pharmacology & toxicology,
M Basista, and
L Grodzińska, and
R J Gryglewski
June 2010,
Research in veterinary science,
M Basista, and
L Grodzińska, and
R J Gryglewski
January 1982,
Polish journal of pharmacology and pharmacy,
M Basista, and
L Grodzińska, and
R J Gryglewski
December 1997,
Inflammation research : official journal of the European Histamine Research Society ... [et al.],
M Basista, and
L Grodzińska, and
R J Gryglewski
January 1979,
Agents and actions. Supplements,
M Basista, and
L Grodzińska, and
R J Gryglewski
November 1998,
The Journal of pharmacology and experimental therapeutics,
M Basista, and
L Grodzińska, and
R J Gryglewski
April 1994,
Proceedings of the National Academy of Sciences of the United States of America,
M Basista, and
L Grodzińska, and
R J Gryglewski
November 1997,
Inflammation research : official journal of the European Histamine Research Society ... [et al.],
M Basista, and
L Grodzińska, and
R J Gryglewski
November 2004,
The Journal of the American Osteopathic Association,
